Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

		Cancer Friends Network > Types of Cancer > Adrenocortical Carcinoma
Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-11-2012, 02:30 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,193

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 09:19 AM.

CancerFriends.net